Mitemcinal Uses, Dosage, Side Effects and more
Mitemcinal (GM-611) is a novel erythromycin-derived prokinetic agent that acts as an agonist at the motilin receptor.
| Trade Name | Mitemcinal |
| Generic | Mitemcinal |
| Mitemcinal Other Names | Mitemcinal |
| Type | |
| Formula | C40H69NO12 |
| Weight | Average: 755.987 Monoisotopic: 755.481976666 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in gastroparesis and irritable bowel syndrome (IBS).
How Mitemcinal works
Mitemcinal, an oral motilin agonist, accelerates gastric emptying.
